e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Login
Search all ERS
e-learning
resources
COVID-19
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
Global Lung Function Initiative
e-learning
Case reports
CME Online
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
VALUE-Dx
Courses and events
COVID-19
Disease Areas
Events
Publications
Guidelines
e-learning
VALUE-Dx
Login
Search
Neuromuscular consequences of respiratory diseases
Oral Presentation
Chairs:
S. Vergès (Grenoble, France), C. Spengler (Zürich, Switzerland)
Download all media
Brain oxygenation state during the 6-minute walking test in patients with COPD
T. Kutsuzawa (Isehara Kanagawa, Japan)
Late Breaking Abstract - Is there a role for cardiopulmonary exercise testing in identifying COPD patients most likely to respond to morphine?
S. Abdallah (Montréal, QC, Canada)
Genetic variants predicting the response to endurance exercise training are also associated with skeletal muscle oxidative capacity in COPD
H. Rossiter (Hermosa Beach, United States of America)
Smoking does not impair locomotor muscle oxidative capacity in humans with normal spirometry
A. Adami (Torrance, United States of America)
Reduced ventilatory efficiency and muscle endurance in smokers with normal spirometry
A. Elsayed Ahmed (London, United Kingdom)
Altered muscle metabolism and muscle mass in patients with COPD
L. Persson (Linkoping, Sweden)
Reduced voluntary activation and increased intracortical inhibition during leg extensions in severe obstructive sleep apnoea patients.
M. MARILLIER (Echirolles, France)
Cortical disorders and muscle weakness in COPD: impact of neuromodulation on intracortical inhibition
V. Cabibel (Montpellier, France)
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept